TipRanks
Go Ultimate55% OFF

Acrivon Therapeutics, Inc. (ACRV) Balance Sheet

Acrivon Therapeutics, Inc. Balance Sheet

Acrivon Therapeutics, Inc.'s total assets for Q2 2026 were $99.09M, a decrease of 8.11% from the previous quarter. ACRV total liabilities were $12.43M for the fiscal quarter, a 0.89% an increase from the previous quarter. See a summary of the company’s assets, liabilities, and equity.

Balance Sheet
Balance SheetDec 25Dec 24Dec 23Dec 22Dec 21
$ 129.72M$ 196.59M$ 138.26M$ 181.23M$ 106.59M
$ 17.20M$ 19.80M$ 17.07M$ 10.75M$ 130.40M
$ 112.52M$ 176.79M$ 121.19M$ 170.47M$ -23.81M

Currency in USD

Acrivon Therapeutics, Inc. Debt to Assets

080M160M240M0 %200 %400 %600 %LiabilitiesDebt to Assets202020212022202320242025AssetsLiabilitiesDebt to Assets